Similar companies
| Company | Revenue | |
|---|---|---|
 |
Intuitive SurgicalISRG |
2.25B 6.6% |
Income Statement (NONE)
| Q1 '25 | QoQ | |
|---|---|---|
| Revenue | 4.66B | 2.2% |
| Gross Profit | 3.21B | 3.7% |
| Cost of Revenue | 1.45B | 0.9% |
| Operating expense | 2.04B | 15.7% |
| Net Income | 674M | 19.1% |
| EBITDA | 921M | 9.1% |
Balance Sheet (NONE)
| Q1 '25 | QoQ | |
|---|---|---|
| Shares Outstanding | 1.49B | 0.5% |
Cash Flow (NONE)
| Q1 '25 | QoQ |
|---|
EPS
Financial Highlights for Boston Scientific in Q1 '25
Boston Scientific reported a revenue of 4.66B, which is a 2.2% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 3.21B, marking a 3.7% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 1.45B, a -0.9% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 2.04B, showing a -15.7% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 674M, showing a 19.1% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 921M, showing a -9.1% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Boston Scientific with growth in revenue, gross profit, and net income. A decline in EBITDA signals potential operational challenges or increased costs.
